These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 19346482)

  • 41. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.
    Chen K; Reiman EM; Alexander GE; Caselli RJ; Gerkin R; Bandy D; Domb A; Osborne D; Fox N; Crum WR; Saunders AM; Hardy J
    Am J Psychiatry; 2007 Jun; 164(6):916-21. PubMed ID: 17541051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
    Pardo JV; Lee JT;
    eNeuro; 2018; 5(1):. PubMed ID: 29497704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of gray matter atrophy with age, β-amyloid, and cognition in aging.
    Oh H; Madison C; Villeneuve S; Markley C; Jagust WJ
    Cereb Cortex; 2014 Jun; 24(6):1609-18. PubMed ID: 23389995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes.
    Riviere ME; Langbaum JB; Turner RS; Rinne JO; Sui Y; Cazorla P; Ricart J; Meneses K; Caputo A; Tariot PN; Reiman EM; Graf A
    Alzheimers Dement; 2024 Mar; 20(3):1839-1850. PubMed ID: 38145469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissociable influences of
    Ge T; Sabuncu MR; Smoller JW; Sperling RA; Mormino EC;
    Neurology; 2018 May; 90(18):e1605-e1612. PubMed ID: 29592889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner.
    Rubinski A; Dewenter A; Zheng L; Franzmeier N; Stephenson H; Deming Y; Duering M; Gesierich B; Denecke J; Pham AV; Bendlin B; Ewers M;
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1035-1049. PubMed ID: 38049659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in Daily Physical Activity by Alzheimer's Risk Markers Among Older Adults.
    Marino FR; Deal JA; Dougherty RJ; Bilgel M; Tian Q; An Y; Simonsick EM; Resnick SM; Ferrucci L; Spira AP; Wanigatunga AA; Schrack JA
    J Gerontol A Biol Sci Med Sci; 2024 Jul; 79(7):. PubMed ID: 38742659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes.
    Operto G; Cacciaglia R; Grau-Rivera O; Falcon C; Brugulat-Serrat A; Ródenas P; Ramos R; Morán S; Esteller M; Bargalló N; Molinuevo JL; Gispert JD;
    Alzheimers Res Ther; 2018 May; 10(1):48. PubMed ID: 29793545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
    Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ
    Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.
    Villeneuve S; Vogel JW; Gonneaud J; Pichet Binette A; Rosa-Neto P; Gauthier S; Bateman RJ; Fagan AM; Morris JC; Benzinger TLS; Johnson SC; Breitner JCS; Poirier J;
    JAMA Neurol; 2018 May; 75(5):608-619. PubMed ID: 29482212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
    Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
    JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
    Small GW; Siddarth P; Burggren AC; Kepe V; Ercoli LM; Miller KJ; Lavretsky H; Thompson PM; Cole GM; Huang SC; Phelps ME; Bookheimer SY; Barrio JR
    Arch Gen Psychiatry; 2009 Jan; 66(1):81-7. PubMed ID: 19124691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
    Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporal Dynamics of β-Amyloid Accumulation in Aging and Alzheimer Disease.
    Jagust WJ; Landau SM;
    Neurology; 2021 Mar; 96(9):e1347-e1357. PubMed ID: 33408147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
    Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ
    J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease.
    Baek MS; Cho H; Lee HS; Lee JH; Ryu YH; Lyoo CH
    Alzheimers Res Ther; 2020 Oct; 12(1):140. PubMed ID: 33129364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
    Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.